Should past staff members of regulatory agencies be allowed to work for a pharmaceutical company?
According to an article in “The Defender,” “The U.S. Food and Drug Administration (FDA) informs departing workers that they can still influence the agency’s decision-making after leaving their position to work for the pharmaceutical industry.” This comes in response to an investigation done by the British Medical Journal (BMJ).
Craig Holman, governmental affairs lobbyist, was interviewed for this report.
He joins “Defender In-Depth” to share details with CHD.TV viewers.
Don’t miss it!
